Cargando…
Design and validation of recombinant protein standards for quantitative Western blot analysis of cannabinoid CB(1) receptor density in cell membranes: an alternative to radioligand binding methods
BACKGROUND: Replacement of radioligand binding assays with antibody-antigen interaction-based approaches for quantitative analysis of G protein-coupled receptor (GPCR) levels requires the use of purified protein standards containing the antigen. GPCRs in general and cannabinoid CB(1) receptor in par...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479267/ https://www.ncbi.nlm.nih.gov/pubmed/36109736 http://dx.doi.org/10.1186/s12934-022-01914-1 |
_version_ | 1784790750518575104 |
---|---|
author | Saumell-Esnaola, Miquel Elejaga-Jimeno, Ainhoa Echeazarra, Leyre Borrega-Román, Leire Barrondo, Sergio López de Jesús, Maider González-Burguera, Imanol Gómez-Caballero, Alberto Goicolea, María Aranzazu Sallés, Joan García del Caño, Gontzal |
author_facet | Saumell-Esnaola, Miquel Elejaga-Jimeno, Ainhoa Echeazarra, Leyre Borrega-Román, Leire Barrondo, Sergio López de Jesús, Maider González-Burguera, Imanol Gómez-Caballero, Alberto Goicolea, María Aranzazu Sallés, Joan García del Caño, Gontzal |
author_sort | Saumell-Esnaola, Miquel |
collection | PubMed |
description | BACKGROUND: Replacement of radioligand binding assays with antibody-antigen interaction-based approaches for quantitative analysis of G protein-coupled receptor (GPCR) levels requires the use of purified protein standards containing the antigen. GPCRs in general and cannabinoid CB(1) receptor in particular show a progressive tendency to aggregate and precipitate in aqueous solution outside of their biological context due to the low solubility that the hydrophobic nature imprinted by their seven transmembrane domains. This renders full-length recombinant GPCRs useless for analytical purposes, a problem that can be overcome by engineering soluble recombinant fragments of the receptor containing the antigen. RESULTS: Here we generated highly soluble and stable recombinant protein constructs GST-CB1(414–472) and GST-CB1(414-442) containing much of the human CB(1) receptor C-terminal tail for use as standard and negative control, respectively, in quantitative Western blot analysis of CB(1) receptor expression on crude synaptosomes of the adult rat brain cortex. To this end we used three different antibodies, all raised against a peptide comprising the C-terminal residues 443–473 of the mouse CB(1) receptor that corresponds to residues 442–472 in the human homolog. Estimated values of CB(1) receptor density obtained by quantitative Western blot were of the same order of magnitude but slightly higher than values obtained by the radioligand saturation binding assay. CONCLUSIONS: Collectively, here we provide a suitable Western blot-based design as a simple, cost-effective and radioactivity-free alternative for the quantitative analysis of CB(1) receptor expression, and potentially of any GPCR, in a variety of biological samples. The discrepancies between the results obtained by quantitative Western blot and radioligand saturation binding techniques are discussed in the context of their particular theoretical bases and methodological constraints. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12934-022-01914-1. |
format | Online Article Text |
id | pubmed-9479267 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-94792672022-09-17 Design and validation of recombinant protein standards for quantitative Western blot analysis of cannabinoid CB(1) receptor density in cell membranes: an alternative to radioligand binding methods Saumell-Esnaola, Miquel Elejaga-Jimeno, Ainhoa Echeazarra, Leyre Borrega-Román, Leire Barrondo, Sergio López de Jesús, Maider González-Burguera, Imanol Gómez-Caballero, Alberto Goicolea, María Aranzazu Sallés, Joan García del Caño, Gontzal Microb Cell Fact Research BACKGROUND: Replacement of radioligand binding assays with antibody-antigen interaction-based approaches for quantitative analysis of G protein-coupled receptor (GPCR) levels requires the use of purified protein standards containing the antigen. GPCRs in general and cannabinoid CB(1) receptor in particular show a progressive tendency to aggregate and precipitate in aqueous solution outside of their biological context due to the low solubility that the hydrophobic nature imprinted by their seven transmembrane domains. This renders full-length recombinant GPCRs useless for analytical purposes, a problem that can be overcome by engineering soluble recombinant fragments of the receptor containing the antigen. RESULTS: Here we generated highly soluble and stable recombinant protein constructs GST-CB1(414–472) and GST-CB1(414-442) containing much of the human CB(1) receptor C-terminal tail for use as standard and negative control, respectively, in quantitative Western blot analysis of CB(1) receptor expression on crude synaptosomes of the adult rat brain cortex. To this end we used three different antibodies, all raised against a peptide comprising the C-terminal residues 443–473 of the mouse CB(1) receptor that corresponds to residues 442–472 in the human homolog. Estimated values of CB(1) receptor density obtained by quantitative Western blot were of the same order of magnitude but slightly higher than values obtained by the radioligand saturation binding assay. CONCLUSIONS: Collectively, here we provide a suitable Western blot-based design as a simple, cost-effective and radioactivity-free alternative for the quantitative analysis of CB(1) receptor expression, and potentially of any GPCR, in a variety of biological samples. The discrepancies between the results obtained by quantitative Western blot and radioligand saturation binding techniques are discussed in the context of their particular theoretical bases and methodological constraints. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12934-022-01914-1. BioMed Central 2022-09-15 /pmc/articles/PMC9479267/ /pubmed/36109736 http://dx.doi.org/10.1186/s12934-022-01914-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Saumell-Esnaola, Miquel Elejaga-Jimeno, Ainhoa Echeazarra, Leyre Borrega-Román, Leire Barrondo, Sergio López de Jesús, Maider González-Burguera, Imanol Gómez-Caballero, Alberto Goicolea, María Aranzazu Sallés, Joan García del Caño, Gontzal Design and validation of recombinant protein standards for quantitative Western blot analysis of cannabinoid CB(1) receptor density in cell membranes: an alternative to radioligand binding methods |
title | Design and validation of recombinant protein standards for quantitative Western blot analysis of cannabinoid CB(1) receptor density in cell membranes: an alternative to radioligand binding methods |
title_full | Design and validation of recombinant protein standards for quantitative Western blot analysis of cannabinoid CB(1) receptor density in cell membranes: an alternative to radioligand binding methods |
title_fullStr | Design and validation of recombinant protein standards for quantitative Western blot analysis of cannabinoid CB(1) receptor density in cell membranes: an alternative to radioligand binding methods |
title_full_unstemmed | Design and validation of recombinant protein standards for quantitative Western blot analysis of cannabinoid CB(1) receptor density in cell membranes: an alternative to radioligand binding methods |
title_short | Design and validation of recombinant protein standards for quantitative Western blot analysis of cannabinoid CB(1) receptor density in cell membranes: an alternative to radioligand binding methods |
title_sort | design and validation of recombinant protein standards for quantitative western blot analysis of cannabinoid cb(1) receptor density in cell membranes: an alternative to radioligand binding methods |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479267/ https://www.ncbi.nlm.nih.gov/pubmed/36109736 http://dx.doi.org/10.1186/s12934-022-01914-1 |
work_keys_str_mv | AT saumellesnaolamiquel designandvalidationofrecombinantproteinstandardsforquantitativewesternblotanalysisofcannabinoidcb1receptordensityincellmembranesanalternativetoradioligandbindingmethods AT elejagajimenoainhoa designandvalidationofrecombinantproteinstandardsforquantitativewesternblotanalysisofcannabinoidcb1receptordensityincellmembranesanalternativetoradioligandbindingmethods AT echeazarraleyre designandvalidationofrecombinantproteinstandardsforquantitativewesternblotanalysisofcannabinoidcb1receptordensityincellmembranesanalternativetoradioligandbindingmethods AT borregaromanleire designandvalidationofrecombinantproteinstandardsforquantitativewesternblotanalysisofcannabinoidcb1receptordensityincellmembranesanalternativetoradioligandbindingmethods AT barrondosergio designandvalidationofrecombinantproteinstandardsforquantitativewesternblotanalysisofcannabinoidcb1receptordensityincellmembranesanalternativetoradioligandbindingmethods AT lopezdejesusmaider designandvalidationofrecombinantproteinstandardsforquantitativewesternblotanalysisofcannabinoidcb1receptordensityincellmembranesanalternativetoradioligandbindingmethods AT gonzalezburgueraimanol designandvalidationofrecombinantproteinstandardsforquantitativewesternblotanalysisofcannabinoidcb1receptordensityincellmembranesanalternativetoradioligandbindingmethods AT gomezcaballeroalberto designandvalidationofrecombinantproteinstandardsforquantitativewesternblotanalysisofcannabinoidcb1receptordensityincellmembranesanalternativetoradioligandbindingmethods AT goicoleamariaaranzazu designandvalidationofrecombinantproteinstandardsforquantitativewesternblotanalysisofcannabinoidcb1receptordensityincellmembranesanalternativetoradioligandbindingmethods AT sallesjoan designandvalidationofrecombinantproteinstandardsforquantitativewesternblotanalysisofcannabinoidcb1receptordensityincellmembranesanalternativetoradioligandbindingmethods AT garciadelcanogontzal designandvalidationofrecombinantproteinstandardsforquantitativewesternblotanalysisofcannabinoidcb1receptordensityincellmembranesanalternativetoradioligandbindingmethods |